A booming biologics market is increasing demand for specialist fill-finish services and prompting contractors to invest in technologies that reduce waste and safeguard these sensitive medicines. The ...
Building a solid commercial drug strategy is centered on engaging partners strategically and at the earliest stage possible. Drug developers need partners with a wide range of experience that can ...
SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results